How AI helped Medvi, a telehealth provider of GLP-1 weight-loss drugs with just two employees, hit $401M in 2025 sales; it's tracking for $1.8B in 2026 sales
Matthew Gallagher took just two months, $20,000 and more than a dozen artificial intelligence tools to get his start-up off the ground.
New York TimesErin Griffith
Context & Ripple Effects
Medvi’s reported scale turns a familiar AI promise—automating a company’s operating stack—into an unusually concentrated telehealth case: a launch assembled in roughly two months and run with two full-time employees. It belongs alongside healthcare AI coverage that has ranged from AI-assisted drug discovery workflows to tools that automate administrative work in medtech companies.
Medvi can handle more telehealth activity per employee by assembling operational tasks across multiple AI tools, reducing the time and staffing needed to launch and scale its service.
The same model puts Medvi’s customer acquisition and operating practices under closer scrutiny, given related coverage’s concerns about potentially scam-like marketing and business conduct.
Second-order effects
Telehealth and medtech operators face pressure to automate customer-facing and back-office workflows; the funding of AI tools for sales recaps and CRM entry in medtech shows adjacent healthcare vendors are already productizing pieces of that stack.
As AI lowers operating overhead, differentiation shifts toward distribution, clinical and service quality, and controls over how automated systems are used—not simply the ability to deploy tools.
Third-order effects
If repeatable, this model could lower the minimum organizational size needed to build consumer-health businesses, concentrating more economic output in small teams that orchestrate third-party AI systems.
In healthcare, the durability of that shift will depend on whether governance around marketing, patient interactions, and accountability keeps pace with the falling cost of automated work.
The trend: Medvi is one data point in the rise of AI-native healthcare businesses that use workflow automation to substitute software orchestration for traditional early-stage headcount.
It's just an automated GLP-1 prescription mill — nothing to lionize. — How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company — https://www.nytimes.com/...
Me: grew up in a trailer park, nyt just released an article about my startup going from $0-$1b arr in 14 months with one employee Random guy on X: this is fake and gay This is why I'm not active on social media lol
@anothercohen @pitdesi Yeah, I don't believe any of it. I saw another one yesterday with the same pitch that claimed to have gone to $100M arr in a few weeks.
cool- but I don't understand it. There are 100s of GLP factories that prescribe GLP's after a few Q's Medvi's flow is particularly bad. I assume margins would have been competed away Hims did $2.35B of revenue with 2k employees. This 2 person co in the space is doing $1.8B?
There's so many observations here: - This is the “check a box” era of medicine - These companies do not need to raise much VC b/c the development cost is near zero - Pick the prescription, target the user, simplify the process, the equation is simple https://www.nytimes.com/...
this is your absolutely must read of the day one man (now two) runs a billion dollar GLP-1 retail operation with ai tooling 80m in profits, and 1m donated to cat rescue truly remarkable
So I don't think this can be real. It would make no sense that he'd want to share this data, including that he works with CareValidate as his Telemedicine provider, if this were true. If you really have this secret $3m/day money printing machine, the absolute worst thing you can
When everyone else is building AI-powered picks and shovels, the one guy who wants to actually dig can do $400 million in sales with no employees https://www.nytimes.com/... [image]
This story is ostensibly about how effective AI is at running a business, but I think it's probably more about how offering GLP-1s via telehealth is such a gangbusters business you literally can't NOT make money doing it https://www.nytimes.com/...
Sam Altman predicted in 2024 that a one-person billion-dollar company “would have been unimaginable without A.I., and now it will happen.” He just emailed the NYT saying he won a bet with tech CEO friends over when it would arrive, and that he “would like to meet the guy.” The [i…